IBDEI36G ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,50733,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50733,1,3,0)
 ;;=3^Malig Neop Bronchus/Lung,Unspec Part
 ;;^UTILITY(U,$J,358.3,50733,1,4,0)
 ;;=4^C34.90
 ;;^UTILITY(U,$J,358.3,50733,2)
 ;;=^5000966
 ;;^UTILITY(U,$J,358.3,50734,0)
 ;;=C65.9^^193^2497^154
 ;;^UTILITY(U,$J,358.3,50734,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50734,1,3,0)
 ;;=3^Malig Neop Renal Pelvis,Unspec
 ;;^UTILITY(U,$J,358.3,50734,1,4,0)
 ;;=4^C65.9
 ;;^UTILITY(U,$J,358.3,50734,2)
 ;;=^5001253
 ;;^UTILITY(U,$J,358.3,50735,0)
 ;;=C50.912^^193^2497^135
 ;;^UTILITY(U,$J,358.3,50735,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50735,1,3,0)
 ;;=3^Malig Neop Left Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,50735,1,4,0)
 ;;=4^C50.912
 ;;^UTILITY(U,$J,358.3,50735,2)
 ;;=^5001196
 ;;^UTILITY(U,$J,358.3,50736,0)
 ;;=C50.911^^193^2497^157
 ;;^UTILITY(U,$J,358.3,50736,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50736,1,3,0)
 ;;=3^Malig Neop Right Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,50736,1,4,0)
 ;;=4^C50.911
 ;;^UTILITY(U,$J,358.3,50736,2)
 ;;=^5001195
 ;;^UTILITY(U,$J,358.3,50737,0)
 ;;=C50.919^^193^2497^127
 ;;^UTILITY(U,$J,358.3,50737,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50737,1,3,0)
 ;;=3^Malig Neop Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,50737,1,4,0)
 ;;=4^C50.919
 ;;^UTILITY(U,$J,358.3,50737,2)
 ;;=^5001197
 ;;^UTILITY(U,$J,358.3,50738,0)
 ;;=C62.90^^193^2497^165
 ;;^UTILITY(U,$J,358.3,50738,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50738,1,3,0)
 ;;=3^Malig Neop Testis,Unspec
 ;;^UTILITY(U,$J,358.3,50738,1,4,0)
 ;;=4^C62.90
 ;;^UTILITY(U,$J,358.3,50738,2)
 ;;=^5001236
 ;;^UTILITY(U,$J,358.3,50739,0)
 ;;=D03.9^^193^2497^170
 ;;^UTILITY(U,$J,358.3,50739,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50739,1,3,0)
 ;;=3^Melanoma in Situ,Unspec
 ;;^UTILITY(U,$J,358.3,50739,1,4,0)
 ;;=4^D03.9
 ;;^UTILITY(U,$J,358.3,50739,2)
 ;;=^5001908
 ;;^UTILITY(U,$J,358.3,50740,0)
 ;;=C45.0^^193^2497^171
 ;;^UTILITY(U,$J,358.3,50740,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50740,1,3,0)
 ;;=3^Mesothelioma of Pleura
 ;;^UTILITY(U,$J,358.3,50740,1,4,0)
 ;;=4^C45.0
 ;;^UTILITY(U,$J,358.3,50740,2)
 ;;=^5001095
 ;;^UTILITY(U,$J,358.3,50741,0)
 ;;=C90.01^^193^2497^173
 ;;^UTILITY(U,$J,358.3,50741,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50741,1,3,0)
 ;;=3^Multiple Myeloma,In Remission
 ;;^UTILITY(U,$J,358.3,50741,1,4,0)
 ;;=4^C90.01
 ;;^UTILITY(U,$J,358.3,50741,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,50742,0)
 ;;=C90.00^^193^2497^174
 ;;^UTILITY(U,$J,358.3,50742,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50742,1,3,0)
 ;;=3^Multiple Myeloma,Not in Remission
 ;;^UTILITY(U,$J,358.3,50742,1,4,0)
 ;;=4^C90.00
 ;;^UTILITY(U,$J,358.3,50742,2)
 ;;=^5001752
 ;;^UTILITY(U,$J,358.3,50743,0)
 ;;=C94.6^^193^2497^175
 ;;^UTILITY(U,$J,358.3,50743,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50743,1,3,0)
 ;;=3^Myelodysplastic Disease NEC
 ;;^UTILITY(U,$J,358.3,50743,1,4,0)
 ;;=4^C94.6
 ;;^UTILITY(U,$J,358.3,50743,2)
 ;;=^5001846
 ;;^UTILITY(U,$J,358.3,50744,0)
 ;;=D61.82^^193^2497^176
 ;;^UTILITY(U,$J,358.3,50744,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50744,1,3,0)
 ;;=3^Myelophthisis
 ;;^UTILITY(U,$J,358.3,50744,1,4,0)
 ;;=4^D61.82
 ;;^UTILITY(U,$J,358.3,50744,2)
 ;;=^334037
 ;;^UTILITY(U,$J,358.3,50745,0)
 ;;=D47.9^^193^2497^177
 ;;^UTILITY(U,$J,358.3,50745,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50745,1,3,0)
 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior
